TABLE 1

Patients’ characteristics

Parameter (unit)Patients with type 2 diabetesSubjects with IGTHealthy control subjectsP*
Sex (M/F)5/31/73/5
Age (years)64 ± 963 ± 1062 ± 70.89
Height (cm)166 ± 5161 ± 6167 ± 80.48
Weight (kg)80.4 ± 21.881.9 ± 13.277.5 ± 14.70.87
BMI (kg/m2)28.9 ± 7.231.7 ± 6.427.7 ± 4.80.43
HbA1c (%)7.7 ± 1.35.7 ± 0.45.4 ± 0.50.001
Diabetes duration (years)10 ± 9
Antidiabetic therapy (n)
 Diet alone3
 Sulfonylureas5
 Metformin0
 Acarbose0
Fasting glucose (mg/dl)187 ± 7499 ± 999 ± 90.0014
120-min glucose (mg/dl)NA165 ± 18123 ± 7<0.001
Total cholesterol (mg/dl)211 ± 42267 ± 65226 ± 350.092
Triglycerides (mg/dl)160 ± 69266 ± 216140 ± 520.17
Systolic blood pressure (mmHg)149 ± 20129 ± 14135 ± 180.083
Diastolic blood pressure (mmHg)78 ± 775 ± 879 ± 110.70
Creatinine (mg/dl)1.0 ± 0.11.0 ± 0.21.1 ± 0.10.71
  • Data are means ± SD unless otherwise indicated.

  • *

    * Determined by analysis of variance. NA, not applicable.